GPT and metabolic dysfunction-associated steatotic liver disease: Additionally, Klisic et al. [9] examined the discriminatory capability of endocan related to NAFLD and found that this biomarker seems to be more reliable in the diagnostic assessment of NAFLD when combined with other biomarkers (e.g., gender, HbA1c, HDL-c, alanine aminotransferase, hsCRP).